# Risk Factors for Advanced Fibrosis Among FLD Patients

> **NCT05971082** · — · UNKNOWN · sponsor: **Helsinki University Central Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- NAFLD
- Liver Cirrhosis
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** Follow-up

## Key facts

- **NCT ID:** NCT05971082
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05971082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05971082, "Risk Factors for Advanced Fibrosis Among FLD Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05971082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*